F-star Therapeutics Inc

NASDAQ:FSTX   3:59:51 PM EDT
2.52
+0.14 (+5.88%)
Earnings Announcements

F-Star Therapeutics Reports Q1 Net Loss Of $0.57 Per Share, For Common Shareholders

Published: 05/10/2022 12:15 GMT
F-star Therapeutics Inc (FSTX) - Cash and Cash Equivalents Were $68.8 Million As of March 31, 2022.
Net Loss Attributable to Common Shareholders Was $0.57 per Share, for Quarter Ended March 31, 2022.
Q1 Earnings per Share View $-0.67 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $2.08 Million
Adjusted EPS is expected to be -$0.60

Next Quarter Revenue Guidance is expected to be $1.06 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.